Atrial Fibrillation in Practice

Gregory YH Lip MD FRCP (Lond Edin Glasg) DFM FESC FACC is Professor of Cardiovascular Medicine and Director of the Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham. His research interests range from clinical (atrial fibrillation, hypertension, heart failure, ethnicity and vascular disease, etc) to the laboratory (thrombogenesis, atherogenesis and vascular biology in cardiovascular disease and stroke). He has published extensively on the clinical epidemiology and pathophysiology of thrombogenesis in atrial fibrillation, and the use of antithrombotic therapy.

1. Epidemiology and importance 2. Aetiology 3. Pathophysiology and electrophysiology 4. Clinical features 5. Investigations 6. Non-drug management 7. Drug management 8. Management strategies 9. Antithrombotic therapy